Pulmonary Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
Photon-counting CT protocol shows promise for lung imaging

Photon-counting CT protocol shows promise for lung imaging

Study finds improved survival in patients with SLE-associated PAH

Study finds improved survival in patients with SLE-associated PAH

Mechanical thrombectomy improves symptoms, quality of life in patients with pulmonary embolism

Mechanical thrombectomy improves symptoms, quality of life in patients with pulmonary embolism

Researchers perform in-utero surgery to repair a potentially deadly developmental condition

Researchers perform in-utero surgery to repair a potentially deadly developmental condition

One-third of patients with chronic thromboembolic pulmonary hypertension also have left heart disease

One-third of patients with chronic thromboembolic pulmonary hypertension also have left heart disease

The effect of moderate intensity exercise in pregnant women with cardiovascular disease

The effect of moderate intensity exercise in pregnant women with cardiovascular disease

Scientists find a good treatment target for pulmonary hypertension

Scientists find a good treatment target for pulmonary hypertension

Fixed-dose combination therapy provides better results than monotherapy for pulmonary hypertension

Fixed-dose combination therapy provides better results than monotherapy for pulmonary hypertension

Jersey Shore University Medical Center celebrates the opening of new Pulmonary Hypertension Center

Jersey Shore University Medical Center celebrates the opening of new Pulmonary Hypertension Center

Pulmonary morphopathology in COVID-19 caused by the B.1.617.2 Delta variant

Pulmonary morphopathology in COVID-19 caused by the B.1.617.2 Delta variant

Repression of endothelial TLR3 is a potential mechanism of SARS-CoV-2 infection-associated lung vascular remodeling

Repression of endothelial TLR3 is a potential mechanism of SARS-CoV-2 infection-associated lung vascular remodeling

Treatment to boost white blood cells may benefit patients with glioblastoma

Treatment to boost white blood cells may benefit patients with glioblastoma

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Dapagliflozin improves morbidity reduces risk of death in heart failure patients

Dapagliflozin improves morbidity reduces risk of death in heart failure patients

Researchers identify micronutrient supplementation to reduce cardiovascular risk

Researchers identify micronutrient supplementation to reduce cardiovascular risk

Scientists report new target to combat coronary artery disease

Scientists report new target to combat coronary artery disease

Study offers a systems biology strategy to facilitate the search for effective COVID-19 drugs

Study offers a systems biology strategy to facilitate the search for effective COVID-19 drugs

Patients with autoimmune diseases at greater risk of complications after heart attack

Patients with autoimmune diseases at greater risk of complications after heart attack

New guidelines recommend earlier detection and treatment of pulmonary hypertension

New guidelines recommend earlier detection and treatment of pulmonary hypertension

Carbon monoxide foam in the fight against inflammation

Carbon monoxide foam in the fight against inflammation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.